Malcolm presents at ICI: Innovation in Cardiovascular Intervention (Tel Aviv)

News/Insights

Malcolm presents at ICI: Innovation in Cardiovascular Intervention (Tel Aviv)

JPM 2026 – Coronary Microvascular Disease coming into focus

Echopoint Medical joins leading cardiovascular accelerator program

Exciting Times at LSI USA 2025 – Advancing Heart Health in Women

Visit of Tim van de Hoef to Echopoint’s offices

London, Feb 11, 2025 – Echopoint was honoured to welcome Dr. Tim van De Hoef, a renowned Interventional Cardiologist from the University Medical [...]

Closing the Women’s Health Gap: A Blueprint for Global Impact

The latest World Economic Forum report, in collaboration with the McKinsey Health Institute, highlights the urgent need to address inequities in women’s health. [...]

Attendance at JPM 2025 in San Francisco

Exciting times for the Echopoint Medical team at #JPM2025 in San Francisco! We had the pleasure of attending both the RESI JPM Conference [...]

Echopoint Medical Ltd Welcomes Nancy Briefs as Chair of the Board

Echopoint Medical Ltd is pleased to announce the appointment of Nancy Briefs as our new Chair of the Board. Nancy brings a wealth [...]

UCL Spinout Echopoint Medical Ltd Secures £4.2 Million in Series A Funding, Advancing FDA Approval Process for iKOr System

London, 20thth February 2024 Echopoint Medical, an innovative force in cardiovascular diagnostic technology and a spinout from UCL, announces a £4.2 million in Series [...]

Echopoint Medical starts its first in human study at Barts Heart Centre (London, UK).

This milestone was recognised by the Financial Times and with coverage by Clive Cookson.

Echopoint Medical obtain regulatory approval for a First-in-Human study in the United Kingdom from the Medicines and Healthcare products Regulatory Agency (MHRA)

News/Insights